OUR STORY

Giving HOPE where there is none

20 years ago, we launched MING Medical with a bold vision to revolutionize healthcare through Cell-based Medicine. Our goal was to lead the development of innovative cell-based solutions that offer a powerful alternative to traditional treatment methods. Today, regenerative medicine—especially Stem Cell therapy and live NK-Cell immunotherapy for cancer (side-effect free)—has emerged as the game-changing future of healthcare, with the potential to transform disease management, particularly for the aging population.

Conventional medicine struggles to keep up with the needs of our aging society. Degenerative diseases and age-related genetic mutations, like cancer, demand solutions that amplify the body’s natural ability to heal and defend itself. That’s where MING comes in. Our non-invasive anti-aging therapy is designed to regenerate aging and damaged tissues, while supercharging the body’s immune system to fight cancer.

Regenerative Medicine and NK-Cell Immunotherapy are already proving that aging can be slowed or reversed, and that diseases like cancer can be tackled more effectively. MING, alongside our dedicated research partners, is united in our mission to bring this groundbreaking hope to everyone—at an affordable price.

We are now focused on delivering treatments for conditions that were once deemed untreatable or irreversible. These include Human Corneas for Transplants, Beta Cells for Diabetes, NK Cells for End-Stage Cancer, and Stem Cells for non-invasive treatments in diseases where surgery is the current go-to.

We look to giving HOPE, where all is deemed lost.

Sean Ng
Founder & Managing Director